Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01885143 · ClinicalTrials.gov registry record
A Case Collection Study for Digital Breast Tomosynthesis (DBT) Using the Senographe Essential
A clinical trial of Image Correction, sponsored by GE Healthcare.
- Completed
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT01885143 is a study of Image Correction that has completed, run by GE Healthcare. The registered enrollment target is 80 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01885143, a study of Image Correction, has completed, sponsored by GE Healthcare.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Collect clinical images requested by FDA with GE Breast Tomosynthesis to show they are of acceptable quality as defined in the relevant FDA guidance document before and after artifact correction and in standard screening images. Lossy compression will also be evaluated to demonstrate that images are of acceptable quality when lossy compression is enabled.
Conditions Studied
Interventions
- RADIATION Digital Breast Tomosynthesis
Study Locations (1)
Michigan
- Beaumont Hospitals - Royal Oak
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2013-08 |
| Est. Completion | 2014-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01885143
The ClinicalTrials.gov registry entry for NCT01885143 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GE Healthcare, which has 99 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Image Correction appearing as the primary indexed condition, and to 1 intervention - of which Digital Breast Tomosynthesis is the first listed.
NCT01885143 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT01885143 about?
NCT01885143 is a clinical study titled "A Case Collection Study for Digital Breast Tomosynthesis (DBT) Using the Senographe Essential". Collect clinical images requested by FDA with GE Breast Tomosynthesis to show they are of acceptable quality as defined in the relevant FDA guidance document before and after artifact correction and in standard screening images. Lossy compression will also be evaluated to demonstrate that images are...
What is the current status of trial NCT01885143?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2013-08. Estimated completion is 2014-06.
What conditions does trial NCT01885143 study?
This clinical trial studies the following conditions: Image Correction.
What interventions are being tested in trial NCT01885143?
The interventions under investigation include: Digital Breast Tomosynthesis (RADIATION).
Who is sponsoring clinical trial NCT01885143?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01885143 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.